PROTECTION FOR BOTH ADOLESCENTS AND ADULTS
Vaccinate against pertussis, tetanus, and diphtheria
The number of pertussis cases reported in 2004 was at a 45-year high.1,2 In fact, 25,827 cases of pertussis were reported to the Centers for Disease Control and Prevention (CDC) that year.2
ADACEL vaccine is the first tetanus, diphtheria, and acellular pertussis (Tdap) booster vaccine available for both adolescents and adults 11 through 64 years of age.
Learn more about pertussis—ask your doctor if ADACEL vaccine is right for you and your family.
References: 1. Centers for Disease Control and Prevention (CDC). Summary of notifiable diseases-United States, 1994. Published Oct. 6, 1995, for MMWR. 1994;43(53):77. Hyattsville, MD: 2004. 2. CDC. Notice to readers: final 2004 reports of notifiable diseases. MMWR. 2005;54(31):770-780.
SAFETY INFORMATION
Indication
Adacel vaccine is given as a single dose to people 11 through 64 years of age for active booster immunization for the prevention of tetanus (lockjaw), diphtheria, and pertussis (whooping cough).
Safety Information
Side effects to Adacel vaccine include injection site pain, redness, and swelling; headache, body ache, tiredness, and fever. Tell your doctor if you have ever experienced a severe brain disorder, such as encephalopathy (altered consciousness) or Guillain-Barré syndrome (severe muscle weakness), after a previous dose of a tetanus toxoid- or pertussis-containing vaccine. Other side effects may occur. Vaccination with Adacel vaccine may not protect all people receiving the vaccine.
For more information about Adacel vaccine, talk to your health-care professional.
Last modified: 2/20/09
